Novartis Annual Report 2009 Home

|

|

|

|

|

||

ANNUAL REPORT 2009

HEALTHCARE
PORTFOLIO

CORPORATE
CITIZENSHIP

CORPORATE
GOVERNANCE

COMPENSATION
REPORT

FINANCIAL
REPORT

GROUP REVIEW >

	News from 2009
	Letter from Daniel Vasella

CORPORATE GOVERNANCE >

	Our Board of Directors
	Our Management

HEALTHCARE PORTFOLIO >

	Emerging Markets Feature Story
	Pharmaceuticals
	Research and Development
	Vaccines and Diagnostics
	Sandoz
	Consumer Health

COMPENSATION REPORT >

Compensation report

CORPORATE CITIZENSHIP >

	Patients
	People and Communities
	Environment
	Ethical Business Conduct
	Independent Assurance Report

FINANCIAL REPORT >

	Operating and Financial Review
	Equity Strategy
	Novartis Group Consolidated Financial Statement
	Novartis AG Financial Statements

IMAGE GALLERY >

Latest news

23-Jul-2010
Sandoz leads the way with first generic version of 'gold standard' anti-thrombotic Lovenox®[1]

Visit our newsroom

Use of this website is governed by our Terms of use and Privacy policy. © 2010 Novartis AG